Literature DB >> 27517291

CCN family of proteins: critical modulators of the tumor cell microenvironment.

Herman Yeger1, Bernard Perbal2.   

Abstract

The CCN family of proteins consisting of CCN1 (Cyr61), CCN2 (CTGF), CCN3 (NOV), CCN4 (WISP-1), CCN5 (WISP-2) and CCN6 (WISP-3) are considered matricellular proteins operating essentially in the extracellular microenvironment between cells. Evidence has also been gradually building since their first discovery of additional intracellular roles although the major activity is triggered at the cell membrane. The proteins consist of 4 motifs, a signal peptide (for secretion} followed consecutively by the IGFBP, VWC, TSP1 and CT (C-terminal cysteine knot domain) motifs, which signify their potential binding partners and functional connections to a variety of key regulators of physiological processes. With respect to cancer it is now clear that, whereas certain members can facilitate tumor behavior and progression, others can competitively counter the process. It is therefore clear that the net outcome of biological interactions in the matrix and what gets signaled or inhibited can be a function of the interplay of these CCN 1-6 proteins. Because the CCN proteins further interact with other key proteins, like growth factors in the matrix, the balance is not only important but can vary dynamically with the physiological states of tumor cells and the surrounding normal cells. The tumor niche with its many cell players has surfaced as a critical determinant of tumor behavior, invasiveness, and metastasis. It is in this context that CCN proteins should be investigated with the potential of being recognized and validated for future therapeutic approaches.

Entities:  

Keywords:  CCN proteins; Cancer

Year:  2016        PMID: 27517291      PMCID: PMC5055503          DOI: 10.1007/s12079-016-0346-6

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  106 in total

1.  CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis.

Authors:  James Hutchenreuther; Krista M Vincent; David E Carter; Lynne-Marie Postovit; Andrew Leask
Journal:  J Invest Dermatol       Date:  2015-07-13       Impact factor: 8.551

2.  Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.

Authors:  Heyun Zhang; Wenbin Li; Pinbo Huang; Lehang Lin; Hua Ye; Dechen Lin; H Phillip Koeffler; Jie Wang; Dong Yin
Journal:  Oncol Rep       Date:  2015-01-08       Impact factor: 3.906

3.  The CCN family of genes: a perspective on CCN biology and therapeutic potential.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-06-21       Impact factor: 5.782

4.  A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.

Authors:  Zhulin Yang; Zhi Yang; Qiong Zou; Yuan Yuan; Jinghe Li; Daiqiang Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

Review 5.  Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer.

Authors:  Julia E Wells; Meegan Howlett; Catherine H Cole; Ursula R Kees
Journal:  Int J Cancer       Date:  2014-05-30       Impact factor: 7.396

6.  Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour.

Authors:  A W Rachfal; M H Luquette; D R Brigstock
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

Review 7.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

8.  The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression.

Authors:  Yu-Ting Huang; Qiang Lan; Lionel Ponsonnet; Marisa Blanquet; Gerhard Christofori; Jelena Zaric; Curzio Rüegg
Journal:  Oncotarget       Date:  2016-01-12

9.  Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study.

Authors:  David J Klinke
Journal:  PLoS Comput Biol       Date:  2014-01-09       Impact factor: 4.475

Review 10.  CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?

Authors:  Qingan Jia; Qiongzhu Dong; Lunxiu Qin
Journal:  Oncotarget       Date:  2016-01-12
View more
  22 in total

1.  SMYD3-associated pathway is involved in the anti-tumor effects of sulforaphane on gastric carcinoma cells.

Authors:  Qing-Qing Dong; Qiu-Tong Wang; Lei Wang; Ya-Xin Jiang; Mei-Ling Liu; Hai-Jie Hu; Yong Liu; Hao Zhou; Hong-Peng He; Tong-Cun Zhang; Xue-Gang Luo
Journal:  Food Sci Biotechnol       Date:  2018-03-22       Impact factor: 2.391

2.  Clinical relevance of Cyr61 expression in patients with hormone-dependent breast cancer.

Authors:  Sebastian Mayer; Thalia Erbes; Sylvia Timme-Bronsert; Markus Jaeger; Gerta Rücker; Franciska Kuf; Elmar Stickeler; Gerald Gitsch; Marc Hirschfeld
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

Review 3.  Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers.

Authors:  Andrew Leask
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-04       Impact factor: 4.249

4.  Myeloid deficiency of CCN3 exacerbates liver injury in a mouse model of nonalcoholic fatty liver disease.

Authors:  Wenconghui Wu; Xingjian Hu; Xianming Zhou; Philip A Klenotic; Qi Zhou; Zhiyong Lin
Journal:  J Cell Commun Signal       Date:  2017-12-06       Impact factor: 5.782

Review 5.  An early history of CCN2/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin.

Authors:  Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2017-10-26       Impact factor: 5.782

6.  CTGF/CCN2 facilitates LRP4-mediated formation of the embryonic neuromuscular junction.

Authors:  Bisei Ohkawara; Akinori Kobayakawa; Shunsuke Kanbara; Takako Hattori; Satoshi Kubota; Mikako Ito; Akio Masuda; Masaharu Takigawa; Karen M Lyons; Naoki Ishiguro; Kinji Ohno
Journal:  EMBO Rep       Date:  2020-06-17       Impact factor: 8.807

Review 7.  The CCN axis in cancer development and progression.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2021-04-20       Impact factor: 5.782

8.  [Regulatory effect of CCN3 on proliferation of mouse embryonic fibroblasts and its mechanism].

Authors:  Shiyu Chen; Xin Su; Junping Liu; Yutong Shi; Minmin Wu; Mengqi Xu; Fengmei Zhang; Min Tang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

9.  Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.

Authors:  Joshua D Campbell; Christina Yau; Reanne Bowlby; Yuexin Liu; Kevin Brennan; Huihui Fan; Alison M Taylor; Chen Wang; Vonn Walter; Rehan Akbani; Lauren Averett Byers; Chad J Creighton; Cristian Coarfa; Juliann Shih; Andrew D Cherniack; Olivier Gevaert; Marcos Prunello; Hui Shen; Pavana Anur; Jianhong Chen; Hui Cheng; D Neil Hayes; Susan Bullman; Chandra Sekhar Pedamallu; Akinyemi I Ojesina; Sara Sadeghi; Karen L Mungall; A Gordon Robertson; Christopher Benz; Andre Schultz; Rupa S Kanchi; Carl M Gay; Apurva Hegde; Lixia Diao; Jing Wang; Wencai Ma; Pavel Sumazin; Hua-Sheng Chiu; Ting-Wen Chen; Preethi Gunaratne; Larry Donehower; Janet S Rader; Rosemary Zuna; Hikmat Al-Ahmadie; Alexander J Lazar; Elsa R Flores; Kenneth Y Tsai; Jane H Zhou; Anil K Rustgi; Esther Drill; Ronglei Shen; Christopher K Wong; Joshua M Stuart; Peter W Laird; Katherine A Hoadley; John N Weinstein; Myron Peto; Curtis R Pickering; Zhong Chen; Carter Van Waes
Journal:  Cell Rep       Date:  2018-04-03       Impact factor: 9.423

Review 10.  Cellular communication network factor 3 in cartilage development and maintenance.

Authors:  Satoshi Kubota; Harumi Kawaki; Bernard Perbal; Kazumi Kawata; Takako Hattori; Takashi Nishida
Journal:  J Cell Commun Signal       Date:  2021-06-14       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.